药物对比
Tirzepatide vs Vildagliptin
Tirzepatide 与 Vildagliptin 治疗 2 型糖尿病的比较：注射用双重激动剂 vs 口服 DPP-4 抑制剂。疗效更强、体重减轻更多 vs 使用便利，前者有黑框警告而后者无。
此页面暂无可用的对比维度。
临床背景
This comparison arises when type 2 diabetes patients on oral therapies like Vildagliptin seek more potent options for better control and weight management.
结论
Tirzepatide often outperforms Vildagliptin in efficacy and weight loss but requires injection and carries a black box warning unlike the oral Vildagliptin.
全部药物对比